Sharps Technology, Inc. STSS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

38/100

1/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Sharps Technology, Inc. (STSS) generated $752.88K in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $189.51M, free cash flow was $190.26M.

Free cash flow margin was -186119.6% of revenue. Cash conversion ratio was -0x, suggesting some earnings are non-cash.

Criteria supported by this page:

HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
MOAT (11/100, Fail) — limited free cash flow weakens the competitive position
INCOME (10/100) — Cash conversion ratio was -0x suggests some earnings are non-cash items

Overall SharesGrow Score: 37/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

38/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✓

FUTURE

100/100

Analyst consensus

→ Forecast

✗

PAST

25/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

11/100

Proven by this page

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Sharps Technology, Inc. Cash Flow History

Metric	TTM	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q4 FY2024
Operating Cash Flow	$-10.3M	$752.88K	$-7.39M	$-1.91M	$-1.76M
Capital Expenditure	$21.26K	$189.51M	$-187.55M	$-1.87M	$-69.15K
Free Cash Flow	$-10.28M	$190.26M	$-194.93M	$-3.77M	$-1.83M